Related Experiment Video
Updated: Jan 11, 2026

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
Published on: December 2, 2014
An Update on the Treatment of Arterial Stiffness
1Arterial Hypertension, Metabolic Unit, University Hospital, Fundacion Favaloro, Buenos Aires, Argentina.
None:
Arterial stiffness, a hallmark of cardiovascular aging and disease, is characterized by the reduced elasticity of the arterial walls, which increases cardiovascular risk. Effective treatment aims not only to manage symptoms but also to address underlying causes and reduce associated risks. Thus, the present study aims to provide an understanding of lifestyle modifications and pharmaco-logical treatments for arterial stiffness, as well as the associated cardiovascular risk. The cornerstone of arterial stiffness treatment involves lifestyle changes. Regular aerobic physical activity, com-bined with a healthy diet, can help reduce weight, lower blood pressure, and improve arterial func-tion. Moreover, since tobacco use directly damages arterial walls and promotes stiffness, smoking cessation is necessary. Several classes of medication, such as renin-angiotensin-aldosterone system inhibitors and calcium channel blockers, not only help control blood pressure but also improve arterial compliance. New antidiabetic agents, such as SGLT2 inhibitors and GLP-1 receptor agonists, have been shown to have beneficial effects on arterial stiffness. Statins, which are commonly prescribed for cholesterol management, also have favorable effects on arterial health, beyond their lipid-lowering properties. In conclusion, treating arterial stiffness is a multifaceted process that involves lifestyle modifica-tions, medication, and emerging therapies, all of which are best achieved through consistent moni-toring. This holistic approach aims to enhance arterial elasticity, reduce cardiovascular risk, and improve overall quality of life.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Aortic Regurgitation III: Medical Management
Hypertension IV: Drug Therapy and Lifestyle Modifications

